ARWR
WatchlistArrowhead Pharmaceuticals, Inc.
Healthcare · NASDAQ
$11.4B mkt cap
Brief updated Jun 18, 2026
Arrowhead Pharmaceuticals, Inc., founded in 1989 and based in Pasadena, California, is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for complex and challenging-to-treat diseases within the United States. The company's extensive therapeutic pipeline primari
ARWR is a watchlist-conviction name in Healthcare
ARWR sits at the intersection of key themes currently active in the market. The scoring engine rates it watchlist based on how well the active market forces line up with its business, plus available fundamental data. Financial metrics and analyst consensus provide additional context.
Why now
The market forces active right now are aligned with the company's core business exposure. The timing reflects the intersection of theme strength and available catalyst data.
Key risks
Data availability limits full scoring across all dimensions. Market forces can reverse rapidly; theme exposure does not guarantee the price follows. Fundamental valuation data may not reflect the most recent quarterly results.
What to watch
Monitor conviction score changes, especially the macro and analyst dimensions. Earnings guidance updates and analyst consensus shifts are the primary near-term catalysts.
Stocks Fall on Escalation of US-Iran Hostilities
The escalation of US-Iran hostilities has led to a decline in stock markets, as investors become increasingly risk-averse due to the potential for further conflict and its impact on global stability and oil prices.
Jun 4, 2026
Stocks Fall on Escalation of US-Iran Hostilities
The escalation of US-Iran hostilities has led to a decline in stock markets, as investors become increasingly risk-averse due to the potential for further conflict and its impact on global stability and oil prices.
Jun 4, 2026
Stocks Fall on Escalation of US-Iran Hostilities
The escalation of US-Iran hostilities has led to a decline in stock markets, as investors become increasingly risk-averse due to the potential for further conflict and its impact on global stability and oil prices.
Jun 4, 2026
Stocks Fall on Escalation of US-Iran Hostilities
The escalation of US-Iran hostilities has led to a decline in stock markets, as investors become increasingly risk-averse due to the potential for further conflict and its impact on global stability and oil prices.
Jun 4, 2026
Earnings surprises
+14.7%
2026-05
-63.3%
2026-02
-61.3%
2025-11
-34.0%
2025-08
+4683.3%
2025-05
Generated Thu, 18 Jun 2026 05:09:27 GMT by Decifer intelligence engine. For informational purposes only — not investment advice. Decifer Intelligence Hub.